Mao X - Search Results

1

Clinical impact of uncommon epidermal growth factor receptor exon 19 insertion-deletion variants on epidermal growth factor receptor-tyrosine kinase inhibitor efficacy in non-small-cell lung cancer.

Peng X, Long X, Liu L, Zeng L, Yang H, Jiang W, Liao D, Li K, Wang J, Lizaso A, Mao X, Xu Q, Mansfield AS, Yang N, Zhang Y. Peng X, et al. Among authors: mao x. Eur J Cancer. 2020 Dec;141:199-208. doi: 10.1016/j.ejca.2020.10.005. Epub 2020 Nov 7. Eur J Cancer. 2020. PMID: 33171317

2

Clinical Characteristics and Molecular Patterns of RET-Rearranged Lung Cancer in Chinese Patients.

Zhang K, Chen H, Wang Y, Yang L, Zhou C, Yin W, Wang G, Mao X, Xiang J, Li B, Zhang T, Fei S. Zhang K, et al. Among authors: mao x. Oncol Res. 2019 May 7;27(5):575-582. doi: 10.3727/096504018X15344979253618. Epub 2018 Aug 21. Oncol Res. 2019. PMID: 30131091 Free PMC article.

3

Unique genomic profiles obtained from cerebrospinal fluid cell-free DNA of non-small cell lung cancer patients with leptomeningeal metastases.

Ying S, Ke H, Ding Y, Liu Y, Tang X, Yang D, Li M, Liu J, Yu B, Xiang J, Mao X, Han-Zhang H, Hu W, Chen L. Ying S, et al. Among authors: mao x. Cancer Biol Ther. 2019;20(4):562-570. doi: 10.1080/15384047.2018.1538614. Epub 2018 Nov 5. Cancer Biol Ther. 2019. PMID: 30395779 Free PMC article.

4

Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib.

Su Y, Long X, Song Y, Chen P, Li S, Yang H, Wu P, Wang Y, Bing Z, Cao Z, Cao L, Wu Y, Zhang Z, Liu J, Li B, Xiang J, Ma K, Zhang T, Zhang L, Mao X, Liu H, Xing P, Liang N. Su Y, et al. Among authors: mao x. Target Oncol. 2019 Apr;14(2):159-168. doi: 10.1007/s11523-019-00631-x. Target Oncol. 2019. PMID: 30895431

5

Different Types of ROS1 Fusion Partners Yield Comparable Efficacy to Crizotinib.

He Y, Sheng W, Hu W, Lin J, Liu J, Yu B, Mao X, Zhang L, Huang J, Wang G. He Y, et al. Among authors: mao x. Oncol Res. 2019 Aug 8;27(8):901-910. doi: 10.3727/096504019X15509372008132. Epub 2019 Mar 25. Oncol Res. 2019. PMID: 30940295 Free PMC article.

6

The in cis compound EGFR mutations in Chinese advanced non-small cell lung cancer patients.

Li M, Zhou CZ, Yang JJ, Lu S, Zheng D, Hu J, Zeng H, Lu Y, Lu KH, Li SA, Mao XR, Han-Zhang H, Lizaso A, Ye JY, Hu CP. Li M, et al. Cancer Biol Ther. 2019;20(8):1097-1104. doi: 10.1080/15384047.2019.1595280. Epub 2019 Apr 16. Cancer Biol Ther. 2019. PMID: 30990107 Free PMC article.

7

Durable Clinical Response of Lung Adenocarcinoma Harboring EGFR 19Del/T790M/in trans-C797S to Combination Therapy of First- and Third-Generation EGFR Tyrosine Kinase Inhibitors.

Zhou Z, Zhao Y, Shen S, Gu L, Niu X, Xu Y, Zhang T, Xiang J, Mao X, Lu S. Zhou Z, et al. Among authors: mao x. J Thorac Oncol. 2019 Aug;14(8):e157-e159. doi: 10.1016/j.jtho.2019.04.020. Epub 2019 May 7. J Thorac Oncol. 2019. PMID: 31075545 Free article. No abstract available.

8

Frequency, clinical features and differential response to therapy of concurrent ALK/EGFR alterations in Chinese lung cancer patients.

Liu J, Mu Z, Liu L, Li K, Jiang R, Chen P, Zhou Q, Jin M, Ma Y, Xie Y, Xiang J, Li B, Ma Y, Mao X, Zhang L, Zhang T, Wu D. Liu J, et al. Among authors: mao x. Drug Des Devel Ther. 2019 May 23;13:1809-1817. doi: 10.2147/DDDT.S196189. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31213769 Free PMC article.

9

Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients.

Hu X, Yang D, Li Y, Li L, Wang Y, Chen P, Xu S, Pu X, Zhu W, Deng P, Ye J, Zhang H, Lizaso A, Liu H, Mao X, Huang H, Chu Q, Hu C. Hu X, et al. Among authors: mao x. Cancer Biol Med. 2019 Aug;16(3):556-564. doi: 10.20892/j.issn.2095-3941.2018.0506. Cancer Biol Med. 2019. PMID: 31565484 Free PMC article.

10

Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non-small cell lung cancer patients.

Ding Y, Zhang L, Guo L, Wu C, Zhou J, Zhou Y, Ma J, Li X, Ji P, Wang M, Zhu W, Shi C, Li S, Wu W, Zhu W, Xiao D, Fu C, He Q, Sun R, Mao X, Lizaso A, Li B, Han-Zhang H, Zhang Z. Ding Y, et al. Among authors: mao x. Thorac Cancer. 2020 Jan;11(1):103-112. doi: 10.1111/1759-7714.13208. Epub 2019 Nov 6. Thorac Cancer. 2020. PMID: 31692283 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,123 results

Search Page

Filters